|
|
|
This is the preliminary program for the 2006 Joint Statistical
Meetings in Seattle, Washington.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2006 Program page |
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
50
|
Sun, 8/6/06, 4:00 PM - 5:50 PM | CC-204 |
| Strengths and Weaknesses of a Megatrial - Topic Contributed - Papers | ||
|
Biopharmaceutical Section, Biometrics Section, ENAR |
||
| Organizer(s): Vipin Arora, Novartis Pharmaceuticals Corporation, Tsushung A. Hua, Novartis Pharmaceuticals Corporation | ||
| Chair(s): John E. Connett, University of Minnesota | ||
| 4:05 PM |
Megatrials: Not Necessarily Either/Or —  Lloyd Fisher, University of Washington
|
|
| 4:25 PM |
Issues in the Use of a Composite Endpoint in Megatrials — Steven Snapinn, Amgen Inc.
|
|
| 4:45 PM |
Are Megatrials Worth It? — Barry Davis, The University of Texas School of Public Health
|
|
| 5:05 PM |
Strengths and Weaknesses of a Megatrial: Complexity of Designing, Handling, and Implementing Megatrials — Timothy Church, University of Minnesota
|
|
| 5:25 PM | Disc: Patrick O'Meara, Pat O'Meara Associates, Inc. | |
| 5:45 PM | Floor Discussion | |
|
JSM 2006
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |